More Post from the Author
- Thomson Reuters Files Documents for Proposed Return of Capital and Share Consolidation Transactions
- [MWC 2026] GSMA zverejnila pecifikciu pouvateskho zitku pre natvne AI aplikcie na telefonovanie
- Newgen lleva a cabo una sesin de debate ejecutiva de alto impacto en Guyana para dar forma al futuro de la inteligencia de decisiones basada en IA
- Payoneer and FundPark Collaborate to Expand Dynamic, Frictionless Credit Access for Global E-Commerce Sellers
- R.H. Boyd Celebrates 130 Years of Legacy, Learning, and Leadership
QuantalX Neuroscience Announces CE MDR Approval, Making Brain Health Assessment Available in the EU
Published on Wed 12 Feb 2025 8:06:42 UTC
The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.
NEW YORK, Feb. 12, 2025 /PRNewswire/ --QuantalX Neuroscience Ltd. is proud to announce that its groundbreaking brain health assessment device, the Delphi-MD, has received CE MDR approval, the European Union's certification under the new Medical Device Regulation (MDR). The CE MDR certification process sets a new benchmark for safety, efficacy, and quality in medical devices. This achievement underscores QuantalX's commitment to innovation and excellence in neurological care.
More Post from the Author
- Thomson Reuters Files Documents for Proposed Return of Capital and Share Consolidation Transactions
- [MWC 2026] GSMA zverejnila pecifikciu pouvateskho zitku pre natvne AI aplikcie na telefonovanie
- Newgen lleva a cabo una sesin de debate ejecutiva de alto impacto en Guyana para dar forma al futuro de la inteligencia de decisiones basada en IA
- Payoneer and FundPark Collaborate to Expand Dynamic, Frictionless Credit Access for Global E-Commerce Sellers
- R.H. Boyd Celebrates 130 Years of Legacy, Learning, and Leadership